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ABSTRACT 
Background. The estimated prevalence of smoking and proportion of deaths due to tobacco in Eastern 
European countries are among the highest in the world. Existing estimates of mortality attributable to 
smoking in the region are mostly indirect. The aim of this analysis was to calculate the proportion of 
tobacco-attributed deaths in three Eastern European countries using individual level cohort data. 
Methods. The PrivMort project established a cohort of relatives of participants in population sample 
surveys in Russia, Belarus and Hungary. Survey participants provided data on smoking habits and vital 
statistics of their close relatives between 1982 and 2013. Population attributable risk fractions (PARF) in 
men (n=99,528) and women (n=77,848) aged 40-79 years were calculated from the prevalence rates of 
smoking and hazard ratios of mortality for smokers vs. non-smokers. Trends in PARF over four 8-year 
time periods (1982-1989, 1990-1997, 1998-2005 and 2006-2013) were examined.  
Results. In men in the most recent period (2006-2013), the proportions of deaths attributable to tobacco 
were 23% in Russia, 22% in Belarus and 22% in Hungary. The respective estimates in women were lower 
(2%, 2% and 13%), possibly due to underestimation of smoking prevalence. PARF estimates have 
declined slightly since the early 1990s in men but increased in women. 
Conclusions. Consistently with existing indirect estimates, our results based on individual level cohort 
data suggest that over one fifth of all deaths in men aged 40-79 years are attributable to tobacco. While 
these proportions are lower in women, the increasing trend is a major concern.  
 
IMPLICATIONS 
This is the first large scale, individual-level cohort study which estimated the mortality attributable to 
tobacco smoking directly in Eastern European population samples. The results confirm previous indirect 
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estimates and show that more than 20% of all deaths in Eastern European men can be attributed to 
tobacco. The study also confirms the increasing trend in smoking-related deaths among women. These 
findings emphasize the importance of targeted policy interventions in Eastern European countries.  
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INTRODUCTION 
Tobacco smoking is one of the leading causes of mortality and morbidity worldwide. It has been 
estimated that tobacco smoke was responsible for 20% of all deaths and 14% of all Disability Adjusted 
Life Years globally in 2013. Among men, smoking causes higher disease burden than any other risk 
factor.
1,2
 Although there has been progress in slowing or reversing the tobacco epidemic in some high 
income countries, many low and middle income countries have witnessed no change or even increase in 
smoking prevalence.
3-5
  
Smoking rates in Eastern Europe have historically been high. A survey in 1996 found prevalence rates 
over 60% among Russian men in all age groups between 18 and 54 years. Although only 5% of older 
women smoked, this figure was over 25% in the younger generation.
6
 In a 2000 survey in Belarus, it was 
reported that 53% of men and 9% of women were current smokers, with a similar pattern by age.
7
 More 
recent data show a small decline in male smoking in both countries since then, but increases among 
women.
4,8
 The situation in Hungary is rather different. Although male smoking rates are also high, at 
31%, they are lower than in Russia and Belarus, while female rates are much higher, at 25%.
9
 
The estimated proportion of deaths due to smoking is also higher in Eastern Europe than in other global 
regions.
10-12
 In order to compare these proportions internationally, previous studies calculated population 
attributable risk fractions (PARF) by adopting an indirect method developed by Peto and colleagues,
10
 
which had the advantage of data parsimony, using only (i) country specific lung cancer death rates and (ii) 
relative risks of mortality from the US based Cancer Prevention Studies (CPS). However, this approach 
makes a number of assumptions, including a constant relative risk associated with smoking across 
different populations and settings, and estimates smoking rates indirectly. A recent large systematic 
review has suggested that relative risks may vary between different parts of the world, although caution is 
required as the review was funded by the tobacco industry.
13
 Consequently, it has been recommended 
that, where data exist, direct estimates of PARF are preferable, using both country specific estimates of 
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the relative risk and prevalence rate of smoking.
10,11
 This may be especially important in Eastern Europe, 
given the particular circumstances and very high rates of lung cancer.
14
 However, as individual level data 
on the relationship between smoking and mortality in Eastern European populations remain sparse,
15
 no 
direct estimates of PARF in sufficiently large cohort studies in the region have been published.  
The aim of these analyses was to estimate the proportions of mortality attributable to tobacco smoking in 
three Eastern European countries, the Russian Federation, Belarus and Hungary, and to examine how the 
proportions of tobacco-attributable deaths in these countries changed between 1982 and 2013, which is a 
period of large socio-political changes and, in parts of the region, unprecedented fluctuations in mortality 
rates.  
METHODS 
Study sample and data collection 
The primary aim of the PrivMort Project is to examine the role of privatization and other societal and 
individual level factors in the mortality crisis of the mid-1990s in Eastern European countries. Details of 
the study design, sample selection and data collection process have been described previously.
16
 Briefly, 
individual level data were collected from random population samples in 30 Russian, 20 Belorussian and 
52 Hungarian medium sized towns. All included towns had between 5,000 and 100,000 inhabitants, and 
were outside the catchment area of the capital cities. In Russia and Belarus settlements were matched 
based on a number of likely predictors of mortality, with deliberate variation in industrial structure 
(mono- versus multi-industrial towns) and the speed of privatization, while in Hungary a random sample 
of eligible towns was selected.  
Data collection took place between January 2014 and December 2015. The selected settlements were first 
divided into street-centered clusters, which were then randomly distributed among the interviewers who 
carried out up to 25 interviews per cluster. A random walk procedure was used to identify households, 
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and one respondent was selected from each, even when more than one family shared the same house. If 
more than one person in the household matched the screening criteria (older than 42 years of age; 
relatives lived in the same settlement between 1980 and 2010), the person whose birthday was closer to 
the date of the survey was selected for the interview.
16
  
Participants were asked to answer extensive questions about their socio-economic circumstances, 
employment history, health and lifestyle, including whether they were regular smokers, ex-smokers or 
never smokers. The full list of topics covered by the questionnaire is described elsewhere.
16 
Respondents 
provided information about themselves and their close relatives (mothers, fathers, siblings (two oldest in 
case of multiple sibships) and partners of female respondents). Vital status of relatives, including the year 
of birth and death (if not alive), were also collected. This indirect approach was originally developed by 
demographers (particularly William Brass) to assess child mortality in low income settings, and often 
referred as “Brass techniques”.17 However, the method based on informants reporting their relatives’ 
mortality can also provide information that could not realistically be obtained otherwise. For example, the 
extension of this method was successfully used to study the relationship of education, smoking and 
alcohol intake with adult mortality in Russia.
18-20
 Overall, 63,073 individuals took part in the study 
(overall response rate 54%) and they provided information on 205,607 relatives.  
The present analyses used data on relatives only. To be comparable with previous estimations of tobacco 
attributable deaths,
12
 the analyses were restricted to the experience of subjects between ages 40 and 79 
years from 1982 to censoring/death. To do so, we excluded individuals who were older than 79 years in 
1982 (beginning of the study period) or younger than 40 years in 2013 (end of the study period) or at the 
time of death. Subjects were further excluded if data on vital statistics, sex or smoking habits were not 
available, or if information on frequency of alcohol intake and education were missing. After these 
exclusions, 177,376 individuals (57,425 Russians, 49,434 Belarussians and 70,517 Hungarians) were 
included in the analysis. 
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Follow up time 
Information was available on the vital status of all individuals (whether he/she was dead or alive) in every 
year between 1982 and 2013. In order to examine temporal changes, these 32 years were divided into four 
8-year periods (1982-1989, 1990-1997, 1998-2005 and 2006-2013). The total follow-up time in each 
period was equal to the number of years spent between the beginning of the period and the year of death 
or the end of the period, whichever came first. For each period, only individuals who were younger than 
80 years at the beginning and older than 39 years at the end of that interval were included in the analysis, 
and only life years within the specified age range counted towards the follow up time.  
Statistical analysis 
As the proportionality assumptions for the Cox proportional hazard models were not met, we used 
flexible parametric survival models to estimate the hazard ratios (HR) of death by smoking status.
21
 Age 
was included in the models as a time-dependent variable with three degrees of freedom. Individuals were 
censored (without reaching the endpoint) if they died from external causes (suicide, homicide or 
accident); this was also done in previous studies because smoking has no (or very limited) impact on risk 
of deaths from external causes.
10-12
 
Kaplan-Meier survival curves in regular and never smokers were plotted for the entire observation period 
between 1982 and 2013. They were adjusted for age, type of relation to respondent (i.e. whether the 
individual was the mother, father, sibling or partner of the respondent), sex of respondent, highest level of 
education and frequency of alcohol intake. The median survival time was calculated as the smallest 
survival time for which the survivor function was less than 0.5. 
HRs of mortality in regular vs. never smokers were calculated separately by sex, country and follow up 
period. In model 1, HRs were adjusted for age, type of relation to respondent and sex of respondent. The 
latter two variables were used to take into account the inaccuracy of reporting by survey participants and 
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the potential biases related to these characteristics. In model 2, the hazard ratios were further adjusted for 
education and frequency of alcohol intake. Additional analyses showed that further adjustment for 
material deprivation and binge drinking did not materially change the results, and these factors were 
therefore not included in the final models. PARFs were calculated from the prevalence rates of regular 
smokers and the respective HRs with the standard formula.
22
 All statistical analysis was carried out using 
the statistical software STATA 13.1 (StataCorp, Texas, US).  
RESULTS 
Characteristics of the analytical sample  
Characteristics of the study sample regarding mortality, smoking and age, separately by sex, country and 
follow up period are shown in table 1.  
Age standardized mortality rates (SMR) indicate that death rates in these study populations followed 
patterns similar to official figures:
23
 In the 1980s Belarus had lower rates of mortality than the other two 
countries for both males and females. Hungary has shown a more or less consistent improvement in 
mortality rates over the last 30 years but mortality fluctuated sharply in Belarus and Russia during the 
1990s and early 2000s, particularly in males, and sustained improvement in these two countries occurred 
only in the most recent decade. 
The prevalence of smoking in men also agreed well with official figures in men; in women, the 
prevalence rates were lower than previous estimates.
23
 Smoking was particularly common in Russian 
men, while Hungarian women smoked more than their Russian or Belorussian counterparts. The data also 
indicated that smoking prevalence declined slowly in men over the 32-year period but the opposite trends 
were seen in women, with prevalence rates increasing steadily in all three countries.  
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Association between smoking and mortality 
Figure 1 in supplementary material shows the adjusted survival curves of regular smokers and non-
smokers across the 32 years of observational period by country and sex. Compared to never smokers, the 
median survival of smokers was shorter by 7, 6 and 8 years in Russian, Belorussian and Hungarian men, 
respectively. Among women, the average difference between smokers and non-smokers in the three 
countries was about 9 years.  
Hazard ratios for the mortality rates comparing regular and never smokers, together with the respective 
estimates of the population attributable risks fractions are shown in table 2. Multivariable adjusted hazard 
ratios remained relatively stable for Russian men, however, in the other subgroups substantial fluctuation 
over time can be seen, with increasing tendencies, especially for women.  
In men, the highest PARF due to smoking was found in the Russian sample in the first follow up period, 
but over time it declined consistently in this country. In Hungarian and Belorussian men, the proportion 
of deaths attributable to smoking increased between the first and second periods (during the early/mid 
1990s), before they leveled off or started to decline in the latest 8-year interval. In women, the proportion 
of deaths due to smoking was the highest in Hungary in all four time periods. Due to low prevalence rates 
and low HRs, PARFs were under 3% in Russia and Belorussia. However, the proportion of smoking 
related deaths increased over time in all three countries, with the steepest rise in Hungarian women.  
In comparison with previously published indirect PARF estimates,
12
 we found that in most time periods 
our figures were somewhat lower than those calculated using the Peto method (Supplementary table 1). 
The difference was particularly large for Hungarian men and Russian women. 
The differences in hazard ratios between study periods, particularly among women, may be genuine (due 
to changing intensity of smoking) but they may also reflect inaccuracy in the retrospective recall and 
reporting of smoking. We have therefore, as a sensitivity analysis, recalculated PARFs using hazard ratios 
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in the last study interval (Supplementary table 2). These alternative estimates, in line with the changes in 
smoking prevalence rates and similarly to our main results, suggest slowly declining trends of tobacco 
attributable mortality over time among men but steep increase in women.  
In addition, we also calculated the HRs of mortality between ever smokers (including ex- and regular 
smokers) and non-smokers (Supplementary table 3). As expected, the results of this sensitivity analysis 
indicated weaker relationship between smoking and mortality compared to our main findings when the 
exposed group was restricted to regular smokers, however the trends over time did not d ffer 
considerably.  
Because the reported prevalence rates of smoking in the PrivMort study may be underestimated, 
particularly in females, we also calculated the PARF values by using prevalence data from the WHO in 
three recent time periods (1990-1997, 1998-2005 and 2006-2013) (Supplementary table 4). These PARFs 
did not differ considerably from our main findings in males. In females, however, WHO prevalence data 
produced much higher estimates of attributable mortality. 
   
DISCUSSION 
Main findings 
In this retrospective cohort study with data collected from relatives of study participants in three Eastern 
European countries, trends in male mortality and smoking prevalence were similar to official figures 
between 1982 and 2013. Smoking prevalence in women was lower than expected, most likely due to 
under-reporting. In multivariable models, the proportion of deaths attributable to smoking ranged between 
17% and 28% in males and between 0.2% and 13% in females during this 32-year period. PARF in the 
most recent time interval (between 2006 and 2013) was the highest in Russian men and Hungarian 
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women. While the proportion of deaths attributable to smoking have been declining since the early/mid 
90s in men, the data indicated an increasing trend in women.  
Strengths and limitations 
This study is the first that estimated the proportion of deaths attributable to tobacco smoking in 
sufficiently large Eastern European population samples using country-specific individual level cohort 
data. In addition to the large sample size, further advantage is the retrospective cohort design which 
allowed us to estimate PARF due to smoking in the 1990s, in a period when massive social, political and 
economic changes had huge impacts on population health in the region. 
On the other hand, our study also has important weaknesses. The limitations which are related to the 
study design and the indirect data collection process in general have been described in detail previously.
16
 
Most importantly, the convenience cohort based on the Brass method is not directly representative of a 
defined population and the chance of inclusion is not uniform. For example, the probability of inclusion 
for unmarried men or childless individuals was smaller than for others. However, as we obtained 
information from a range of relatives, this effect was minimized. Secondly, the impact of measurement 
error and recall bias can be particularly large when data is collected from proxy informants (i.e. relatives). 
The consequent misclassification may lead to underestimation of the associations` strengths between risk 
factors and mortality, and can reduce the statistical power of the study.  
In addition to these general considerations, several issues specific to this analysis need to be taken into 
account. First, measurement error related to smoking status, and the consequent misclassification of 
individuals in smoker and non-smoker groups, may affect our results. There are a number of reasons for 
this error to occur. (1) Previous validation study found that underreporting of smoking status is especially 
prevalent in Russian females.
24
 Due to cultural stigma associated with smoking and drinking among 
women, it is likely that many participants did not know (or did not admit) that their mothers or sisters 
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were smokers. The comparison of our PARF estimates with those calculated indirectly and those 
estimated using WHO prevalence rates suggests that our method is reliable for males, but less so for 
females. (2) Underreporting of smoking is probably greater in the analysis related to the first two time 
periods (1980s and early/mid 90s) because it is more difficult for the respondents to remember the correct 
smoking habits of relatives who died 25-30 years ago than for those who are still alive or died just a few 
years before the interview. The information regarding the year of death can also be less precise in the 80s 
compared to the 2010s. It is likely that these measurement biases resulted in underestimation of 
HR/PARF in Russian and Belorussian females, and in the earlier periods. 
Second, selection bias and the fact that our sample is not representative for the respective countries as a 
whole also need to be considered. For example, data from the Russian Longitudinal Monitoring Survey 
suggest that female smoking prevalence rates are more than twice as high in the largest cities compared to 
other urban or rural areas in Russia.
25
 The fact that the PrivMort survey collected data only in middle-
sized towns may have also contributed to underestimation of smoking prevalence among Russian females 
and the consequent low PARF in this group. On the other hand, mortality and male smoking prevalence 
rates in this study were similar to other more representative surveys,
23
 which suggest that this sample was 
probably similar to the general population regarding these aspects.  
Third, the role of residual confounding between smoking and mortality cannot be excluded entirely 
because potential confounding factors, such as BMI, diet or physical activity, were not measured and 
were not taken into account. However, reduction of HRs after adjustment for alcohol and education was 
similar to other studies where some of these additional factors were also adjusted for.
11 
Finally, we had no specific information on the number of cigarettes an individual smoked per day, or the 
age when someone took up or gave up smoking. Although we excluded ex-smokers from the “exposed” 
group, the age of initiation and the intensity of smoking can affect the strength of the examined 
associations. In fact, these factors are likely to contribute to the increased HRs and PARFs in later 
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decades, particularly among women. Unfortunately, this information was not captured in the surveys and 
so cannot be confirmed using this dataset.  
Interpretation 
In women, particularly in Russia, the low PARF estimated by our study is probably due to the 
underreporting of smoking prevalence and the non-representativeness of our dataset. In Hungarian men, it 
is likely that our results reflect the actual values more closely than previous indirect estimates. PARF in 
this country was lower than in Russia and Belarus because of the lower smoking prevalence rates, and 
these rates were very similar to those reported by other surveys.
23
 It is possible that the high PARF in 
Hungarian men reported by previous studies is due to high levels of lung-cancer mortality in non-smokers 
in this country. This speculation is supported by a previous study which found that the cumulative risk of 
lung cancer in never smokers was higher in Hungary than other CEE and FSU countries in both men and 
women.
26
 Potential exposures to carcinogens, for example indoor or outdoor air pollution or, given the 
very high incidence of colorectal cancer in Hungary, misdiagnosis of secondary adenocarcinomas as 
primaries, may contribute to explaining these international differences within the region.  
The tendency towards higher HRs in the more recent time periods may be partly due to the fact that 
individuals in the late 1990s and 2000s had a longer smoking career and spent longer time of their life 
smoking than those in the 1980s. In addition, there is known to be a cohort effect among men in the 
countries of the former USSR because of changing access to cigarettes, and thus smoking initiation 
among adolescents, in the 1940s and 1950s.
27
 It is also possible that people in these later decades smoked 
more cigarettes per day or smoked in a different way (inhaled more deeply). For example, the number of 
cigarettes sold in Russia nearly doubled between 1990 and 2004, and sales during this period also 
increased in Belarus.
28
 Higher relative risks in more recent generations, as the tobacco epidemic matures, 
have been described in several previous cohorts as well.
29-31
 However, as noted before, it is likely that 
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misclassification of smokers and non-smokers was more common in individuals who died in the 1980s or 
early 1990s, and this also contributed to the low HRs in the earlier periods.   
The reduction of HRs after adjustment for education and alcohol consumption was more substantial in 
recent years compared to earlier periods, especially in Russian men. This suggests a change in the 
characteristics of smokers over time. In fact, further analysis of the current data (not shown), as well as 
results of other studies,
32
 indicate that socio-economic inequalities in smoking increased as the smoking 
epidemic matures. Changes in the relationship between smoking and other lifestyle and socio-economic 
factors over time could be subject of further investigations.  
Finally, our results mostly correspond well with data from the US which found approximately 10-year 
difference in life expectancy between smokers and non-smokers.
33
 
Conclusion  
This large retrospective cohort study provided direct estimates which are largely consistent with 
previously reported indirect figures, particularly in men. These individual level data confirm that the 
proportion of deaths due to smoking in Eastern Europe is high. The increasing trend in smoking-related 
deaths among women, possibly linked to the post-communist transition, presents an important public 
health issue which need to be targeted by appropriate policy interventions. 
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Table 1. Basic characteristics of the study sample regarding mortality, smoking and age in the four time periods 
   1982-1989   1990-1997   1998-2005   2006-2013 
MALES             
Russia Number of all participants 20,537   23,453   23,322   19,742  
 Number of deaths (per 1000 person-years)  2,586 (19.3)  3,760 (24.2)  4,965 (31.9)  4,165 (30.7) 
 SMR (95% CI)
1
 0.98 (0.95-1.02)  1.08 (1.05-1.12)  1.21 (1.17-1.24)  1.01 (0.98-1.04) 
 Number of regular smokers (%) 11,600 (56.5)  12,978 (55.3)  12,714 (54.5)  10,354 (52.4) 
 Mean age at baseline (SD) 48.1 (10.3)  50.1 (11.0)  52.7 (11.5)  55.8 (11.3) 
Belarus Number of all participants 17,182   19,364   20,207   17,971  
 Number of deaths (per 1000 person-years)  2,002 (17.4)  2,804 (21.7)  3,821 (28.4)  3,477 (28.2) 
 SMR (95% CI)
 1
 0.88 (0.84-0.92)  0.96 (0.92-0.99)  1.06 (1.03-1.10)  0.94 (0.91-0.97) 
 Number of regular smokers (%) 8,646 (50.3)  9,744 (50.3)  10,130 (50.1)  8,849 (49.2) 
 Mean age at baseline (SD) 48.6 (10.5)  50.5 (11.0)  52.6 (11.9)  55.1 (11.9) 
Hungary Number of all participants 27,742   28,973   27,479   23,538  
 Number of deaths (per 1000 person-years)  4,225 (23.2)  4,604 (23.7)  5,087 (27.1)  4,367 (26.7) 
 SMR (95% CI)
 1
 1.08 (1.05-1.11)  1.02 (0.99-1.05)  0.96 (0.93-0.99)  0.80 (0.78-0.82) 
 Number of regular smokers (%) 10,341 (37.3)  10,593 (36.6)  9,831 (35.8)  8,163 (34.7) 
 Mean age at baseline (SD) 49.2 (11.1)   51.0 (11.1)   54.2 (11.4)   57.2 (11.4) 
FEMALES             
Russia Number of all participants 20,011   20,386   18,492   14,676  
 Number of deaths (per 1000 person-years)  1,933 (13.9)  2,491 (17.4)  3,108 (24.0)  2,375 (23.4) 
 SMR (95% CI)
 1
 0.96 (0.92-1.01)  0.96 (0.92-1.00)  1.04 (1.01-1.08)  0.85 (0.82-0.88) 
 Number of regular smokers (%) 351 (1.8)  512 (2.5)  616 (3.3)  627 (4.3) 
 Mean age at baseline (SD) 51.9 (11.2)  54.8 (11.6)  58.1 (11.7)  61.1 (11.4) 
Belarus Number of all participants 15,906   16,758   16,298   13,755  
 Number of deaths (per 1000 person-years)  1,303 (11.8)  1,742 (14.8)  2,219 (19.6)  1,853 (19.3) 
 SMR (95% CI)
 1
 0.86 (0.81-0.91)  0.88 (0.84-0.92)  0.90 (0.86-0.93)  0.76 (0.73-0.80) 
 Number of regular smokers (%) 242 (1.5)  325 (1.9)  423 (2.6)  449 (3.3) 
 Mean age at baseline (SD) 51.2 (11.2)  53.9 (11.7)  56.8 (12.2)  59.4 (12.0) 
Hungary Number of all participants 24,496   24,591   22,377   18,394  
 Number of deaths (per 1000 person-years)  2,748 (16.4)  2,998 (17.4)  3,176 (20.2)  2,536 (19.8) 
 SMR (95% CI)
 1
 1.11 (1.07-1.16)  1.02 (0.98-1.05)  0.90 (0.87-0.93)  0.73 (0.70-0.76) 
 Number of regular smokers (%) 1,935 (7.9)  2,609 (10.6)  2,865 (12.8)  2,733 (14.9) 
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 Mean age at baseline (SD) 51.6 (11.5)   54.2 (11.7)   57.9 (11.6)   60.7 (11.3) 
1
SMR (standardized mortality rate) is calculated using the pooled population in the first period (1982-1989) as the standard (separately for males 
and females) 
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Table 2. Hazard ratios of mortality and population attributable risk due to smoking in the four time periods 
  1982-1989  1990-1997  1998-2005  2006-2013 
  HR (95% CI) PARF (95% CI) 
 
HR (95% CI) PARF (95% CI) 
 
HR (95% CI) PARF (95% CI) 
 
HR (95% CI) PARF (95% CI) 
MALES                     
Russia model1 1.73 (1.56-1.92) 29.2 (24.0-34.2) 
 
1.76 (1.61-1.91) 29.6 (25.2-33.5) 
 
1.90 (1.76-2.04) 32.9 (29.3-36.2) 
 
1.97 (1.82-2.13) 33.7 (30.1-37.2) 
 
model2 1.69 (1.51-1.89) 28.0 (22.4-33.5) 
 
1.64 (1.50-1.80) 26.1 (21.7-30.7) 
 
1.61 (1.49-1.75) 25.0 (21.1-29.0) 
 
1.58 (1.45-1.72) 23.3 (19.1-27.4) 
Belarus model1 1.53 (1.38-1.70) 21.0 (16.0-26.0) 
 
1.86 (1.70-2.04) 30.2 (26.0-34.5) 
 
1.93 (1.79-2.09) 31.8 (28.4-35.3) 
 
1.82 (1.68-1.96) 28.7 (25.1-32.1) 
 
model2 1.46 (1.30-1.63) 18.8 (13.1-24.1) 
 
1.75 (1.58-1.93) 27.4 (22.6-31.9) 
 
1.77 (1.63-1.92) 27.8 (24.0-31.5) 
 
1.57 (1.44-1.70) 21.9 (17.8-25.6) 
Hungary model1 1.58 (1.47-1.70) 17.8 (14.9-20.7) 
 
1.92 (1.79-2.06) 25.2 (22.4-28.0) 
 
1.92 (1.80-2.05) 24.8 (22.3-27.3) 
 
2.05 (1.91-2.20) 26.7 (24.0-29.4) 
  
model2 1.55 (1.43-1.68) 17.0 (13.8-20.2) 
 
1.79 (1.65-1.93) 22.4 (19.2-25.4) 
 
1.72 (1.60-1.84) 20.5 (17.7-23.1) 
 
1.82 (1.69-1.97) 22.2 (19.3-25.2) 
FEMALES                     
Russia model1 1.12 (0.76-1.67) 0.2 (-0.4-1.2) 
 
1.40 (1.03-1.91) 1.0 (0.1 -2.2) 
 
1.77 (1.40-2.24) 2.5 (1.3 -3.9) 
 
1.71 (1.33-2.19) 3.0 (1.4-4.9) 
 
model2 1.09 (0.71-1.60) 0.2 (-0.5-1.1) 
 
1.20 (0.87-1.67) 0.5 (-0.3-1.6) 
 
1.50 (1.17-1.92) 1.6 (0.6 -2.9) 
 
1.40 (1.07-1.82) 1.7 (0.3 -3.4) 
Belarus model1 1.36 (0.88-2.10) 0.5 (-0.2-1.6) 
 
1.25 (0.85-1.82) 0.5 (-0.3-1.5) 
 
1.86 (1.40-2.49) 2.2 (1.0- 3.7) 
 
1.64 (1.18-2.29) 2.1 (0.6 -4.1) 
 
model2 1.45 (0.93-2.25) 0.7 (-0.1-1.8) 
 
1.12 (0.76-1.66) 0.2 (-0.5-1.2) 
 
1.73 (1.28-2.32) 1.9 (0.7 -3.3) 
 
1.67 (1.19-2.33) 2.2 (0.6 -4.2) 
Hungary model1 1.68 (1.42-1.98) 5.1 (3.2 -7.2) 
 
2.00 (1.76-2.29) 9.6 (7.5-12.0) 
 
1.94 (1.72-2.18) 10.7 (8.4-13.1) 
 
2.15 (1.92-2.41) 14.6 (12.1-17.4) 
  model2 1.67 (1.41-1.97) 5.0 (3.1 -7.1)   1.93 (1.69-2.21) 9.0 (6.8-11.4)   1.83 (1.63-2.07) 9.6 (7.5-12.0)   2.01 (1.79-2.26) 13.1 (10.5-15.8) 
model1: adjusted for age, relative status, respondent sex 
model 2: adjusted for age, relative status, respondent sex, alcohol intake and education 
PARF – Population attributable risk fraction (expressed as percentage of total mortality) 
 
34.  
